4basebio (XTER:88Q) Long-Term Capital Lease Obligation : €0.00 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is 4basebio Long-Term Capital Lease Obligation?

4basebio's Long-Term Capital Lease Obligation for the quarter that ended in Jun. 2023 was €0.00 Mil.

4basebio's quarterly Long-Term Capital Lease Obligation increased from Jun. 2022 (€0.00 Mil) to Dec. 2022 (€0.60 Mil) but then declined from Dec. 2022 (€0.60 Mil) to Jun. 2023 (€0.00 Mil).

4basebio's annual Long-Term Capital Lease Obligation increased from Dec. 2020 (€0.08 Mil) to Dec. 2021 (€0.55 Mil) and increased from Dec. 2021 (€0.55 Mil) to Dec. 2022 (€0.60 Mil).

4basebio Long-Term Capital Lease Obligation Historical Data

The historical data trend for 4basebio's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4basebio Long-Term Capital Lease Obligation Chart

4basebio Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Long-Term Capital Lease Obligation

0.08

0.55

0.60

4basebio Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial			-	0.55	-	0.60	-

4basebio (XTER:88Q) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

4basebio Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of 4basebio's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

4basebio (XTER:88Q) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (XTER:88Q) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

4BB:UK

Address

25 Norman Way, Over, Cambridge, GBR, CB24 5QE

Website

https://www.4basebio.com

4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.

4basebio (XTER:88Q) Headlines

No Headlines